On Episode 3 of “Close to the Edge”, GEN welcomes Daphne Zohar, founder and CEO of Pure Tech Health, who discusses her company and its main focus on treating disorders of the BIG (Brain-Immune-Gut) axis.

PureTech Health has about two dozen products in the pipeline, many of which revolve around the company’s main focus—the BIG (Brain-Immune-Gut) axis. Other areas of interest include cancer, neuroscience and long COVID . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge

Previous articleHeart of the Deal: Prothena Executives on the $1.2B Sale of ATTR Amyloidosis Candidate to Novo Nordisk
Next articleFor Cell and Gene Therapy Products, Early Characterization is Critical